v3.26.1
Shareholders’ Deficit (Tables)
12 Months Ended
Dec. 31, 2025
Shareholders’ Deficit [Abstract]  
Schedule of Warrants Outstanding

The following table summarizes the changes in warrants outstanding during the years ended December 31, 2025 and 2024:

 

   Warrants   Weighted-Average
Exercise
Price
 
Outstanding as of December 31, 2023   706   $6,597.35 
Granted   124,687,552    0.48 
Adjustments(1)   22,184,090    1.50 
Exercised   (8,233,183)   (1.50)
Outstanding as of December 31, 2024   138,639,165    0.61 
Adjustments(2)   999,757,963    0.07 
Exercised/settled   (24,790,152)   (0.05)
Outstanding as of December 31, 2025   1,113,606,976   $0.08 
Exercisable as of December 31, 2025   1,113,606,955   $0.07 

 

(1)As previously described, as a result of antidilution provisions and share combination events, the exercise prices of certain warrants were decreased with the number of underlying shares proportionally increased by 22,184,090.

 

(2)As previously described, as a result of the registration reset applicable to the December 2024 series A and B warrants and shareholder approval to the October 2024 series A and B warrants, the exercise prices were decreased with the number of underlying shares proportionally increased by 999,757,963.